pillbase.ru

XIGDUO XR

Active substance: DAPAGLIFLOZIN PROPANEDIOL, METFORMIN HYDROCHLORIDE

TABLET, FILM COATED, EXTENDED RELEASE · DAPAGLIFLOZIN PROPANEDIOL 2.5 mg/1, METFORMIN HYDROCHLORIDE 1000 mg/1

United StatesActive

Marketing holder: AstraZeneca Pharmaceuticals LP

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Products containing dapagliflozin propanediol in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
EU 5
  • Ebymect
    dapagliflozin propanediol monohydrate, metformin hydrochloride
    EMEA/H/C/004162
    AstraZeneca AB
  • Edistride
    dapagliflozin propanediol monohydrate
    EMEA/H/C/004161
    AstraZeneca AB
  • Forxiga
    dapagliflozin propanediol monohydrate
    EMEA/H/C/002322
    AstraZeneca AB
  • Qtern
    saxagliptin, dapagliflozin propanediol monohydrate
    EMEA/H/C/004057
    Astra Zeneca AB
  • Xigduo
    metformin hydrochloride, dapagliflozin propanediol monohydrate
    EMEA/H/C/002672
    AstraZeneca AB
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-57f4-7e7c-ad97-0f99009ecb82,01a1208e-5ca0-79a2-b358-dcfac8eb1f39,01a1208e-a9a1-7bb9-9462-9fdfbb3589ea,01a1208e-aad0-7a55-8e60-91e2839e6490,01a1208f-c398-716a-9ba6-ef910f22aa8e;count=12 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
0310-6225
Registration status
Active
Dispensing
Prescription only
Route
ORAL
Sources
  • product · openFDA NDC · 0310-6225 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 0310-6225 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 0310-6225 · Verified 2026-10-09 · open in source
  • ingredients.1 · openFDA NDC · 0310-6225 · Verified 2026-10-09 · open in source